Jian-ying H. Chuang

250 Wuxing Street
Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.

KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.

Journal: Biochemical pharmacology

Published: February 23, 2026

Oxytocin mediates self-other and inevitability asymmetries in high-conflict moral judgment in schizophrenia.

Oxytocin mediates self-other and inevitability asymmetries in high-conflict moral judgment in schizophrenia.

Journal: Asian journal of psychiatry

Published: January 26, 2026

Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma.

Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma.

Journal: DNA repair

Published: October 25, 2025

Proteasome Assembly Chaperone 3 Defines Metabolic-Immune Programs and Poor Prognosis in Breast Cancer via Multi-Omics Approaches.

Proteasome Assembly Chaperone 3 Defines Metabolic-Immune Programs and Poor Prognosis in Breast Cancer via Multi-Omics Approaches.

Journal: Journal of Cancer

Published: September 30, 2025

A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption.

A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 08, 2025

Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 27, 2025

SOD2-mediated TMZ-resistant Glioblastoma Cells Exhibit Cross-resistance to Irradiation.

SOD2-mediated TMZ-resistant Glioblastoma Cells Exhibit Cross-resistance to Irradiation.

Journal: Anticancer research

Published: June 11, 2025

Calanquinone A suppresses glioma progression via STAT3-mediated regulation of c-Myc and MMP9.

Calanquinone A suppresses glioma progression via STAT3-mediated regulation of c-Myc and MMP9.

Journal: Discover oncology

Published: May 23, 2025

Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.

Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 08, 2025

Development of BACE2-IN-1/tranylcypromine-based compounds to induce steroidogenesis-dependent neuroprotection.

Development of BACE2-IN-1/tranylcypromine-based compounds to induce steroidogenesis-dependent neuroprotection.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 18, 2024

Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma.

Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma.

Journal: Journal of Cancer

Published: November 13, 2024

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.

Journal: Cell death & disease

Published: January 24, 2024

Showing 1-12 of 74

Last Updated: 09/26/2026